review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1025167189 |
P356 | DOI | 10.1007/S11883-000-0093-1 |
P698 | PubMed publication ID | 11122723 |
P2093 | author name string | Kamanna VS | |
Kashyap ML | |||
P2860 | cites work | A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism | Q24646308 |
Identification of scavenger receptor SR-BI as a high density lipoprotein receptor | Q28273182 | ||
Oleate stimulates secretion of apolipoprotein B-containing lipoproteins from Hep G2 cells by inhibiting early intracellular degradation of apolipoprotein B | Q28625242 | ||
Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition | Q28625661 | ||
Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity | Q29617216 | ||
Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol | Q32068503 | ||
Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells | Q33667974 | ||
Heterogeneity of apolipoprotein B: isolation of a new species from human chylomicrons | Q34056613 | ||
Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells | Q34128848 | ||
Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells | Q35822759 | ||
Synergistic interactions between transcription factors control expression of the apolipoprotein AI gene in liver cells | Q36683551 | ||
Effects of Nicotinic Acid Therapy on Plasma High Density Lipoprotein Subfraction Distribution and Composition and on Apolipoprotein A Metabolism | Q37038074 | ||
High Density Lipoprotein Metabolism in Man | Q37047273 | ||
An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cells | Q37278800 | ||
Basic considerations in the reversal of atherosclerosis: significance of high-density lipoprotein in stimulating reverse cholesterol transport | Q38617105 | ||
The pathogenesis of atherosclerosis--an update | Q39726917 | ||
Direct measurement of apoprotein B specific activity in 125I-labeled lipoproteins | Q40160281 | ||
Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein | Q40343323 | ||
Molecular physiology of reverse cholesterol transport | Q40526401 | ||
Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk | Q40594848 | ||
Regulation of hepatic secretion of apolipoprotein B-containing lipoproteins: information obtained from cultured liver cells. | Q40851335 | ||
A docking receptor for HDL cholesterol esters | Q40944548 | ||
Selective uptake of cholesteryl esters from high-density lipoprotein-derived LpA-I and LpA-I:A-II particles by hepatic cells in culture | Q41006869 | ||
Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models | Q41119433 | ||
High density lipoprotein and lipoprotein oxidation. | Q41119449 | ||
Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. | Q41164669 | ||
Regulation of apoB secretion from HepG2 cells: evidence for a critical role for cholesteryl ester synthesis in the response to a fatty acid challenge | Q41173078 | ||
In HepG2 cells, translocation, not degradation, determines the fate of the de novo synthesized apolipoprotein B. | Q41267533 | ||
Evidence for a lack of regulation of the assembly and secretion of apolipoprotein B-containing lipoprotein from HepG2 cells by cholesteryl ester | Q41473085 | ||
Atherogenic lipoproteins and human disease: extending concepts beyond the heart to the kidney | Q41571002 | ||
Effects of lipid lowering therapy on progression of coronary and carotid artery disease | Q41669486 | ||
Role of cholesterol ester mass in regulation of secretion of ApoB100 lipoprotein particles by hamster hepatocytes and effects of statins on that relationship | Q42468943 | ||
Tissue-specific expression of apolipoprotein A-I (ApoA-I) is regulated by the 5'-flanking region of the human ApoA-I gene. | Q42801250 | ||
Cholesterol efflux from cells to immunopurified subfractions of human high density lipoprotein: LP-AI and LP-AI/AII | Q44208764 | ||
Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). | Q45208371 | ||
Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels | Q45881945 | ||
Mechanistic studies of high-density lipoproteins | Q46542322 | ||
Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II. | Q46734243 | ||
High density associated enzymes: their role in vascular biology | Q46928300 | ||
Heterogeneity of apolipoprotein B-100-containing lipoproteins: what we have learnt from kinetic studies | Q47915012 | ||
Protein composition determines the anti-atherogenic properties of HDL in transgenic mice | Q59064040 | ||
Studies of the sites of intracellular degradation of apolipoprotein B in Hep G2 cells | Q67926118 | ||
Characterization of apoA-I-containing lipoprotein subpopulations secreted by HepG2 cells | Q69361623 | ||
Intrahepatic assembly of very low density lipoproteins. Rate of transport out of the endoplasmic reticulum determines rate of secretion | Q69447815 | ||
Pulse-chase studies of the synthesis and intracellular transport of apolipoprotein B-100 in Hep G2 cells | Q70148161 | ||
Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles | Q70164761 | ||
Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man | Q70731976 | ||
Synthesis and secretion of apolipoprotein B from cultured liver cells | Q70785454 | ||
High-Density Lipoproteins Inhibit Cytokine-Induced Expression of Endothelial Cell Adhesion Molecules | Q71799260 | ||
Stimulation of leukocyte/endothelium interaction by oxidized low-density lipoprotein in hairless mice. Involvement of CD11b/CD18 adhesion receptor complex | Q72216875 | ||
Proteolysis and lipid-facilitated translocation are distinct but competitive processes that regulate secretion of apolipoprotein B in Hep G2 cells | Q72571322 | ||
Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport | Q73832914 | ||
Studies on the Effect of Nicotinic Acid on Catecholamine Stimulated Lipolysis in Adipose Tissue in Vitro | Q76461403 | ||
Endothelium and acute coronary syndromes | Q77086221 | ||
Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells | Q77297680 | ||
Lipoprotein classes and coronary disease regression | Q77306690 | ||
Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density | Q77342521 | ||
Regulation of the assembly and secretion of very low density lipoproteins by the liver | Q77477177 | ||
Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice | Q77604676 | ||
Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene | Q77801094 | ||
State-of-the-art update and review: clinical trials of lipid-lowering agents | Q77896411 | ||
Some insulin-like effects of nicotinic acid observed with isolated rat epididymal adipose tissue | Q79056517 | ||
P433 | issue | 1 | |
P921 | main subject | lipoprotein | Q28350 |
niacinamide | Q192423 | ||
P304 | page(s) | 36-46 | |
P577 | publication date | 2000-01-01 | |
P1433 | published in | Current Atherosclerosis Reports | Q20821076 |
P1476 | title | Mechanism of action of niacin on lipoprotein metabolism | |
P478 | volume | 2 |